BridgeBio Pharma, Inc. (BBIO) forecast

BridgeBio Pharma, Inc. (BBIO) forecast: price $68.30, trailing P/E -18.92, forward P/E 19.19. How to read the street's path.

$68.30Price
$13.35BMarket cap
-18.92P/E ?
19.19Forward P/E ?
0.00%Dividend yield ?

The live BBIO price is $68.30. Trailing P/E is -18.92 and forward P/E is 19.19. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the BBIO forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full BBIO quote · Dividends · Price prediction · Academy

Questions

What is BBIO's forward P/E?

The latest forward P/E on Stocklytics is 19.19, against a trailing P/E of -18.92 and a price of $68.30.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.